Synthaverse S.A. (WSE:SVE)
Poland · Delayed Price · Currency is PLN 2.945
-0.010 (-0.34%)
Aug 14, 2026, 5:00 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 223.14 million as of August 14, 2026. Its market cap has decreased by -36.94% in one year.
Market Cap
223.14M
Enterprise Value
305.47M
Revenue
42.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.95
ChartMarket Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 223.14M, an increase of 54.96%. That is a compound annual growth rate of 2.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 223.14M | -13.61% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 580.49M |
| Captor Therapeutics Spolka Akcyjna | 461.89M |
| Bioceltix | 452.54M |
| Ryvu Therapeutics | 404.60M |
| BIOTON | 334.87M |
| Poltreg | 159.15M |
| Molecure | 127.53M |
| Mabion | 122.19M |